NephCure Kidney International ®

Saving Kidneys, Saving Lives

  • Find a Specialist
  • Find a Clinical Trial
  • Donate
  • Living with Kidney Disease
    • Understanding Kidney Disease
    • Understanding Nephrotic Syndrome and Glomerular Disease
    • Treatment Options
    • Managing Your Care
    • Diet and Nutrition
    • Resources A-Z
    • Educational Programs
    • End Stage Renal Disease
    • Just for Kids!
  • Patient Connections
    • Patient Stories
    • Share Your Story
    • NephSpace – Our Online Support Community
    • Patient Support
  • Events
  • Get Involved
    • Join Your Local Community
    • Participate in Research
    • Advocacy
    • Peer Support
    • Donate
  • Research
    • Get Involved in Research
    • Conferences and Meetings
    • Apply for Research Grants
  • About Us
    • Recent News
    • Funded Research
    • Staff
    • Board of Directors
    • Scientific Advisory Board
    • Corporate Partners
  • Donate
    • One Time Donation
    • Give Monthly
    • Donate to an Event

Friedhelm Hildebrandt, M.D.

HildebrandtChief Director of Nephrology at Boston Children’s Hospital
Professor of Pediatrics at Harvard Medical School
Investigator, Howard Hughes Medical Institute

Email: friedhelm.hildebrandt@childrens.harvard.edu 

Dr. Friedhelm Hildebrandt is a clinician and investigator who joined the Boston Children’s Hospital after a distinguished career at the University of Michigan. Dr. Hildebrandt’s clinical interests include hereditary renal disease. His laboratory focuses on identifying novel genes mutated in kidney diseases of children, including Nephrotic Syndrome. He has received multiple awards for his research, including the E. Mead Johnson Award for Pediatric Research from the Society for Pediatric Research, the highest research award given in pediatrics.

Dr. Hildebrandt received his M.D. from Heidelberg University in Germany, completed his clinical training in general pediatrics and pediatric nephrology at Freiburg University Children’s Hospital, and conducted postdoctoral research with Peter Aronson and Peter Igarashi at Yale.

Selected Publications

Gee HY, Ashraf S, Wan X, Vega-Warner V, Esteve-Rudd J, Lovric S, Fang H, Hurd TW, Sadowski CE, Allen SJ, Otto EA, Korkmaz E, Washburn J, Levy S, Williams DS, Bakkaloglu SA, Zolotnitskaya A, Ozaltin F, Zhou W, Hildebrandt F. Mutations in EMP2 cause childhood-onset nephrotic syndrome. Am J Hum Genet. 2014; 94(6), 884-890.

Lovric S, Fang H, Vega-Warner V, Sadowski CE, Gee HY, Halbritter J, Ashraf S, Saisawat P, Soliman NA, Kari JA, Otto EA, Hildebrandt F; Nephrotic Syndrome Study Group. Rapid detection of monogenic causes of childhood-onset steroid-resistant nephrotic syndrome. Clin J Am Soc Nephrol. 2014; 9(6), 1109-1116.

Bates CM, Charlton JR, Ferris ME, Hildebrandt F, Hoshizaki DK, Warady BA, Moxey-Mims MM; Kidney Research National Dialogue. Pediatric kidney disease: tracking onset and improving clinical outcomes. Clin J Am Soc Nephrol. 2014; 9(6), 1141-1143.

Ashraf S, Gee HY, Woerner S, Xie LX, Vega-Warner V, Lovric S, Fang H, Song X, Cattran DC, Avila-Casado C, Paterson AD, Nitschké P, Bole-Feysot C, Cochat P, Esteve-Rudd J, Haberberger B, Allen SJ, Zhou W, Airik R, Otto EA, Barua M, Al-Hamed MH, Kari JA, Evans J, Bierzynska A, Saleem MA, Böckenhauer D, Kleta R, El Desoky S, Hacihamdioglu DO, Gok F, Washburn J, Wiggins RC, Choi M, Lifton RP, Levy S, Han Z, Salviati L, Prokisch H, Williams DS, Pollak M, Clarke CF, Pei Y, Antignac C, Hildebrandt F. ADCK4 mutations promote steroid-resistant nephrotic syndrome through CoQ10 biosynthesis disruption. J Clin Invest. 2013; 123(12), 5179-5189.

Gee HY, Saisawat P, Ashraf S, Hurd TW, Vega-Warner V, Fang H, Beck BB, Gribouval O, Zhou W, Diaz KA, Natarajan S, Wiggins RC, Lovric S, Chernin G, Schoeb DS, Ovunc B, Frishberg Y, Soliman NA, Fathy HM, Goebel H, Hoefele J, Weber LT, Innis JW, Faul C, Han Z, Washburn J, Antignac C, Levy S, Otto EA, Hildebrandt F. ARHGDIA mutations cause nephrotic syndrome via defective RHO GTPase signaling. J Clin Invest. 2013; 123(8), 3243-3253.

About Us

  • Financials
  • Board of Directors
  • Scientific Advisory Board
    • Gerald Appel, M.D., Ph.D.
    • Laura Barisoni, M.D.
    • Ross Cagan, Ph.D.
    • Daniel C. Cattran, M.D.
    • Alessia Fornoni, M.D., Ph.D
    • Marilyn Gist Farquhar, Ph.D.
    • Friedhelm Hildebrandt, M.D.
    • Lawrence B. Holzman, M.D.
    • Frederick Kaskel, M.D., Ph.D.
    • Jeffrey B. Kopp, M.D.
    • Matthias Kretzler, M.D.
    • Marva Moxey-Mims, M.D.
    • Peter Mundel, M.D.
    • Martin R. Pollak, M.D.
    • Jochen Reiser, M.D., Ph.D.
    • Andrey S. Shaw, M.D.
    • Karl Tryggvason, M.D., Ph.D.
    • Roger Wiggins, M.B., B.Chir.
    • Michelle P. Winn, M.D.
  • Ambassadors
  • Contact Us
  • Career Opportunities
  • Policy and Disclaimers

Our Mission

NephCure Kidney International’s ® mission is to accelerate research for effective treatments for rare forms of Nephrotic Syndrome, and to provide education and support that will improve the lives of those affected by these protein-spilling kidney diseases.

Sign up for our emails »

NephCure Kidney International

  • Contact Us
  • Donate
  • Careers
  • Financials
  • Policy and Disclaimers

SHORT ON TIME?

Contact Information

150 S. Warner Road
Suite 402
King of Prussia, PA 19406
1.866 NephCure (637-4287)
info@nephcure.org
EIN: 38-3569922

Follow Us

  • Facebook
  • Twitter

© Copyright 2021 NephCure Kidney International, Inc. All rights reserved worldwide. NephCure Kidney International, and the logo, are federally registered trademarks of NephCure Kidney International, Inc.

Copyright © 2021 · Outreach Pro Theme on Genesis Framework · WordPress · Log in